RU2003117016A - Способ получения латентного антитромбина iii - Google Patents

Способ получения латентного антитромбина iii Download PDF

Info

Publication number
RU2003117016A
RU2003117016A RU2003117016/13A RU2003117016A RU2003117016A RU 2003117016 A RU2003117016 A RU 2003117016A RU 2003117016/13 A RU2003117016/13 A RU 2003117016/13A RU 2003117016 A RU2003117016 A RU 2003117016A RU 2003117016 A RU2003117016 A RU 2003117016A
Authority
RU
Russia
Prior art keywords
range
concentration
buffer
antithrombin iii
sulfate ions
Prior art date
Application number
RU2003117016/13A
Other languages
English (en)
Russian (ru)
Inventor
Йеран КАРЛССОН (SE)
Йеран КАРЛССОН
Original Assignee
Октафарма АГ (CH)
Октафарма Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0004086A external-priority patent/SE0004086D0/xx
Application filed by Октафарма АГ (CH), Октафарма Аг filed Critical Октафарма АГ (CH)
Publication of RU2003117016A publication Critical patent/RU2003117016A/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8128—Antithrombin III
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
RU2003117016/13A 2000-11-08 2001-11-08 Способ получения латентного антитромбина iii RU2003117016A (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE0004086A SE0004086D0 (sv) 2000-11-08 2000-11-08 Preparation process
SE0004086-5 2000-11-08
US25214800P 2000-11-20 2000-11-20
US60/252,148 2000-11-20

Publications (1)

Publication Number Publication Date
RU2003117016A true RU2003117016A (ru) 2004-12-10

Family

ID=26655296

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2003117016/13A RU2003117016A (ru) 2000-11-08 2001-11-08 Способ получения латентного антитромбина iii

Country Status (15)

Country Link
EP (1) EP1332159A1 (pl)
JP (1) JP2004522707A (pl)
KR (1) KR20030057545A (pl)
AU (1) AU2002214468A1 (pl)
BR (1) BR0115188A (pl)
CA (1) CA2428055A1 (pl)
CZ (1) CZ20031277A3 (pl)
EE (1) EE200300218A (pl)
HU (1) HUP0301766A3 (pl)
IL (1) IL155539A0 (pl)
MX (1) MXPA03004030A (pl)
NO (1) NO20032048D0 (pl)
PL (1) PL360410A1 (pl)
RU (1) RU2003117016A (pl)
WO (1) WO2002038610A1 (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030205538A1 (en) 2002-05-03 2003-11-06 Randel Dorian Methods and apparatus for isolating platelets from blood
US7832566B2 (en) 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US20060278588A1 (en) 2002-05-24 2006-12-14 Woodell-May Jennifer E Apparatus and method for separating and concentrating fluids containing multiple components
US7845499B2 (en) 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
SE0203770D0 (sv) * 2002-12-19 2002-12-19 Biovitrum Ab Method of separation
PT1848473E (pt) 2005-02-07 2013-08-28 Hanuman Llc Dispositivo concentrador de plasma
US7694828B2 (en) 2005-04-27 2010-04-13 Biomet Manufacturing Corp. Method and apparatus for producing autologous clotting components
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
JP5479319B2 (ja) 2007-04-12 2014-04-23 バイオメット・バイオロジックス・リミテッド・ライアビリティ・カンパニー ブイ式懸濁液分画システム
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
EP2259774B1 (en) 2008-02-27 2012-12-12 Biomet Biologics, LLC Methods and compositions for delivering interleukin-1 receptor antagonist
US8337711B2 (en) 2008-02-29 2012-12-25 Biomet Biologics, Llc System and process for separating a material
US8313954B2 (en) 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
US9011800B2 (en) 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US9550028B2 (en) 2014-05-06 2017-01-24 Biomet Biologics, LLC. Single step desiccating bead-in-syringe concentrating device

Also Published As

Publication number Publication date
AU2002214468A1 (en) 2002-05-21
NO20032048L (no) 2003-05-07
CA2428055A1 (en) 2002-05-16
WO2002038610A1 (en) 2002-05-16
HUP0301766A2 (hu) 2003-08-28
MXPA03004030A (es) 2004-02-12
HUP0301766A3 (en) 2005-12-28
EP1332159A1 (en) 2003-08-06
PL360410A1 (pl) 2004-09-06
EE200300218A (et) 2003-08-15
KR20030057545A (ko) 2003-07-04
BR0115188A (pt) 2004-02-03
CZ20031277A3 (cs) 2003-08-13
NO20032048D0 (no) 2003-05-07
IL155539A0 (en) 2003-11-23
JP2004522707A (ja) 2004-07-29

Similar Documents

Publication Publication Date Title
RU2003117016A (ru) Способ получения латентного антитромбина iii
DK1140156T3 (da) Oprensning af konjugerede polysaccharidproteinvacciner ved hjælp af ultrafiltrering med ammoniunmsulfatoplösninger
ID27787A (id) Senyawa, komposisi dan metode untuk pengobatan atau pencegahan infeksi yang disebabkan oleh virus dan penyakit-penyakit yang berkaitan
PT702085E (pt) Virus de arn de cadeia negativa nao segmentada infeccioso recombinante
FR2774510B1 (fr) Procede de traitement de substrats, notamment semi-conducteurs
BR9407138A (pt) Método para esterilização de produtos
BR0012619A (pt) Processo para flocular suspensões
DK1358130T3 (da) Fremgangsmåde til fortykning af slam, der hidrörer fra behandling af vand ved flokkulering-klaring med flokfibre som ballast
DK0700300T3 (da) Oprensning af plasmaproteiner
DE60216514D1 (de) Verfahren zur behandlung von dämpferkondensat
EP1399163A4 (en) COMPOUNDS, METHODS AND COMPOSITIONS FOR THE TREATMENT OF BOVINE VIRAL DIARRHEA (VBVD) INFECTION AND HEPATITIS C (HCV) VIRUS INFECTION
DE60330146D1 (de) Verfahren zur reinigung von fibrinogen
DE69900820D1 (de) Wasserdampfplasmabehandlung von glas
DE3763601D1 (de) Verfahren zum isolieren und reinigen von haemin.
DE60131545D1 (de) Verfahren zur behandlung von reaktiver arthritis oder schleimbeutelentzündung
DE60133490D1 (de) Mittel zur entfernung von ablagerungen auf titanwerkstoff
ATE253368T1 (de) Verwendung von bisphosphonaten zur prophylaxe und zur behandlung von infektiösen prozessen
NO960377D0 (no) Hellbare vaskemiddelkonsentrater med uendret eller öket viskositet ved fortynning med vann, og fremgangsmåte for fremstilling av slike
ATE254950T1 (de) Verfahren zur reinigung wässriger pufferlösungen
DE50008992D1 (de) Verfahren zur Inaktivierung von Viren
FR2792309B1 (fr) Procede d'elimination des legionella d'un flux aqueux colonise par electropulsation, procede de traitement d'un flux aqueux par electropulsation, et application a l'elimination des legionella
DE60218485D1 (de) Auflösungshemmende mittel zur herstellung von gereinigten solen
NO20032769D0 (no) Kombinasjonsmetode for behandling av virale infeksjoner
SE0201891D0 (sv) Removal of water-soluble compounds from wood chips prior to cooking
ATE297665T1 (de) Verfahren zur herstellung von tomatenflocken

Legal Events

Date Code Title Description
FA93 Acknowledgement of application withdrawn (no request for examination)

Effective date: 20050301